Heterogeneity of disease classified as stage III in Wilms tumor: A report from the associazione Italiana Ematologia Oncologia Pediatrica (AIEOP)

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 1, 2012, Pages 348-354

  Spreafico, Filippo ^a   Gandola, Lorenza ^a   D'Angelo, Paolo ^b   Terenziani, Monica ^a   Collini, Paola ^a   Bianchi, Maurizio ^c   Provenzi, Massimo ^d   Indolfi, Paolo ^e   Pession, Andrea ^f   Nantron, Marilina ^g   Di Cataldo, Andrea ^h   Marchian, Alfonso ^a   Catania, Serena ^a   Fossati Bellani, Franca ^a   Piva, Luigi ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Ospedale dei Bambini G Di Cristina   (Italy)

^c REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

^d OSPEDALI RIUNITI   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f UNIVERSITY OF BOLOGNA   (Italy)

^g G GASLINI INSTITUTE   (Italy)

^h UNIVERSITY OF CATANIA   (Italy)

Author keywords

Kidney tumors; Lymph node; Radiotherapy; Staging; Wilms tumor

Indexed keywords

ABDOMINAL TUMORS; CLASSIFICATION SYSTEM; DISEASE-FREE SURVIVAL; DOXORUBICIN; LYMPH NODE; OVERALL SURVIVAL RATES; PROSPECTIVE STUDY; RELAPSE RATES; STAGING;

BODY FLUIDS; CHEMOTHERAPY; RADIOTHERAPY;

TUMORS;

DACTINOMYCIN; DOXORUBICIN; VINCRISTINE;

ABDOMINAL RADIOTHERAPY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEPHRECTOMY; NEPHROBLASTOMA; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; THERAPY DELAY; TUMOR CLASSIFICATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DACTINOMYCIN; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; ITALY; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEPHRECTOMY; PROGNOSIS; RADIOTHERAPY DOSAGE; SOCIETIES, MEDICAL; VINCRISTINE; WILMS TUMOR;

EID: 83955161802     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.09.022     Document Type: Article

References (32)

1. D.M. Green, N.E. Breslow, and J.B. Beckwith Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: A report from the National Wilms' Tumor Study Group J Clin Oncol 16 1998 237 245
2. J. de Kraker, N. Graf, and H. van Tinteren Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): A randomised controlled trial Lancet 364 2004 1229 1235
3. C. Mitchell, K. Pritchard-Jones, and R. Shannon Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: Results of a randomised trial (UKW3) by the UK Children's Cancer Study Group Eur J Cancer 42 2006 2554 2562
4. P. Faria, J.B. Beckwith, and K. Mishra Focal versus diffuse anaplasia in Wilms tumor - new definitions with prognostic significance: A report from the National Wilms Tumor Study Group Am J Surg Pathol 20 1996 909 920
5. G.M. Vujanic, B. Sandstedt, and D. Harms Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood Med Pediatr Oncol 38 2002 79 82
6. P.E. Grundy, N.E. Breslow, and S. Li Loss of heterozygosity for chromosome 1p and 16q is an adverse prognostic factor in favorable histology Wilms tumor: A report from the National Wilms Tumor Study Group J Clin Oncol 23 2005 7312 7321
7. D.M. Green, N.E. Breslow, and B. Beckwith Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: A report from the National Wilms' Tumor Study Group J Clin Oncol 19 2001 3719 3724
8. K. Pritchard-Jones, A. Kelsey, and G. Vujanic Older age is an adverse prognostic factor in stage I, favourable histology Wilms' tumor treated with vincristine monochemotherapy: A study by the United Kingdom Children's Cancer Study Group, Wilms Tumor Working Group J Clin Oncol 17 2003 3269 3275
9. H. Chiang-Ching, S. Gadd, and N. Breslow Predicting relapse in favourable histology Wilms tumor using gene expression analysis: A report from the Renal Tumor Committee of the Children's Oncology Group Clin Cancer Res 15 2009 1770 1778
10. N.E. Breslow, S.S. Ou, and G.M. Haase Doxorubicin for favorable histology, stage II-III Wilms tumor. Results from the National Wilms Tumor Studies Cancer 101 2004 1072 1080
11. G.J. D'Angio, A. Evans, and N. Breslow The treatment of Wilms' tumor: Results of the Second National Wilms' Tumor Study Cancer 47 1981 2302 2311
12. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
13. R. Peto, and J. Peto Asymptotically efficient rank invariant test procedures J R Stat Soc A 135 1972 185 206
14. B. Messahel, R. Williams, and A. Ridolfi Allele loss at 16q define poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1-3 clinical trials: A Children's Cancer and Leukaemia Group (CCLG) Study Eur J Cancer 45 2009 819 826
15. S. Hing, Y.J. Lu, and B. Summersgill Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors Am J Pathol 158 2001 393 398
16. R. Natrajan, R.D. Williams, and S.N. Hing Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse J Pathol 210 2006 49 58
17. E.J. Perlman Pediatric renal tumors: Practical updates for the pathologists Pediatr Dev Pathol 8 2005 320 338
18. G.M. Vujanić, D. Harms, and R. Bohoslavsky Nonviable tumor tissue should not upstage Wilms' tumor from stage I to stage II. A report from the SIOP 93-01 nephroblastoma trial and study Pediatr Dev Pathol 12 2008 111 115
19. J.A. Kalapurakal, S.M. Li, and NE. Breslow Intraoperative spillage of favorable histology Wilms tumor cells: Influence of irradiation and chemotherapy regimens on abdominal recurrence. A report from the National Wilms Tumor Study Group Int J Radiat Oncol Biol Phys 76 2010 201 206
20. H.J. Brisse, G. Schleiermacher, and S. Sarnacki Preoperative Wilms tumor rupture: A retrospective study of 57 patients Cancer 113 2008 202 213
21. J.A. Kalapurakal, and D.M. Green Outcomes of children with favorable histology Wilms tumor and peritoneal implants treated in National Wilms Tumor Studies-4 and -5 Int J Radiat Oncol Biol Phys 77 2010 554 558
22. N.E. Breslow, N.F. Palmer, and L.R. Hill Wilms' tumor: Prognostic factors for patients without metastases at diagnosis: Results of the National Wilms' Tumor Study Cancer 41 1978 1577 1589
23. N. Breslow, G. Churchill, and J.B. Becwith Prognosis for Wilms' tumor patients with nonmetastatic disease at diagnosis - results of the second National Wilms' Tumor Study J Clin Oncol 3 1985 521 531
24. N. Breslow, K. Sharples, and J.B. Beckwith Prognostic factors in nonmetastatic, favourable histology Wilms' tumor. Results of the Third National Wilms' Tumor Study Cancer 68 1991 2345 2353
25. B. Jereb, M.F. Tournade, and J. Lemerle Lymph node invasion and prognosis in nephroblastoma Cancer 45 1980 1632 1636
26. M.V. Raval, K.Y. Bilimoria, and D.J. Bentrem Nodal evaluation in Wilms' tumors. Analysis of the National Cancer Data Base Ann Surg 251 2010 559 565
27. R.C. Shamberger, K.A. Guthrie, and M.L. Ritchey Surgery-related factors and local recurrence of Wilms tumor in National Wilms Tumor Study 4 Ann Surgery 229 1999 292 297
28. P.F. Ehrlich, M.L. Ritchey, and T.E. Hamilton Quality assessment for Wilms' tumor: A report from the National Wilms' Tumor Study-5 J Ped Surg 40 2005 208 213
29. H.B. Othersen, A. DeLorimer, and E. Hrabovsky Surgical evaluation of lymph node metastases in Wilms tumor J Ped Surg 25 1990 330 331
30. F. Spreafico, L. Gandola, and M. Terenziani Radical regional lymph node (LN) dissection can avoid irradiation in stage III node-positive Wilms tumor (WT) patients? [abstract] Ped Blood Cancer 45 2005 386
31. A. Pachnis, J. Pritchard, and M. Gaze Radiotherapy omitted in the treatment of selected children under 3 years of age with stage III favorable histology Wilms tumor Med Pediatr Oncol 31 1998 150 152
32. R.G. Grundy, C. Hutton, and H. Middleton Outcome of patients with stage III or inoperable WT treated on the second United Kingdom WT protocol (UKWT2); a United Kingdom Children's Cancer Study Group (UKCCSG) study Pediatr Blood Cancer 42 2004 311 319